Asking the right questions surrounding opioid prescribing in cancer survivorship: Might all pain be cancer‐related?
Cancer · 2024
DOI: 10.1002/cncr.35451 ↗Kurz gefasst
Editorial in der Zeitschrift Cancer, 2024. Verfasst von Eric R Goodlev. Beteiligte Einrichtung: Department of Medicine, Section of Palliative Care, Jefferson Einstein Montgomery Hospital, East Norriton, Pennsylvania, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Cancer Pain, Cancer Survivors. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Current guidance surrounding pain management in cancer survivorship relies heavily on clinicians’ judgement of the pain’s cancer‐relatedness . Rather than asking whether the pain is cancer‐related, instead seek to understand the biopsychosocial and existential context of the pain, and ask whether the benefits of opioid therapy outweigh the risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Section of Palliative Care, Jefferson Einstein Montgomery Hospital, East Norriton, Pennsylvania, USA.
ORCID-Profile: Eric R Goodlev
Zitieren
APA
Goodlev, E. R. (2024). Asking the right questions surrounding opioid prescribing in cancer survivorship: Might all pain be cancer‐related?. Cancer. https://doi.org/10.1002/cncr.35451
Vancouver
Goodlev ER. Asking the right questions surrounding opioid prescribing in cancer survivorship: Might all pain be cancer‐related?. Cancer. 2024. doi:10.1002/cncr.35451
BibTeX
@article{Goodlev2024,
author = {Goodlev, Eric R},
title = {Asking the right questions surrounding opioid prescribing in cancer survivorship: Might all pain be cancer‐related?},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35451}
}
EUVIMED